Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Retrospective Single-centre Cohort Study at the University Hospital of Bern

NCT04444856 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04444856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Retrospective Single-centre Cohort Study at the University Hospital of Bern
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
June 29, 2020
Completion date
January 13, 2021
Enrollment
225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe postpartum haemorrhage